Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV type 1 genetic diversity is a major obstacle for antiretroviral drug resistance hybridization-based assays.

AIDS research and human retroviruses - 10 Oct 2001

Kijak G H, Rubio A E, Quarleri J F, Salomón H

Abstract excerpt

Human immunodeficiency virus type 1 (HIV-1) is characterized by high genetic diversity. Current antiretroviral (ARV) drug resistance genotyping assays have been designed on the basis of the most prevalent sequence patterns circulating in the United States and Europe, which belong to the B subtype. However, little is known about their performance on non-B subtype samples. In Argentina, circulating forms have been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to DNA, Viral
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Reverse Transcriptase

Share to Nucleic Acid Hybridization

Share to Phylogeny

Share to Recombination, Genetic

Source

Identifiers

PMID: 11679154
DOI: 10.1089/088922201753197088

Genes

AGA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV type 1 genetic diversity is a major obstacle for antiretroviral drug resistance hybridization-based assays.PMID 11679154Read ↗

A highly prevalent polymorphism at codon 72 of HIV-1 reverse transcriptase in Argentina prevents hybridization reaction at codon 74 in the LiPA genotyping test.Semantic proximity Read ↗

HIV type 1 diversity in France, 1999-2001: molecular characterization of non-B HIV type 1 subtypes and potential impact on susceptibility to antiretroviral drugs.Semantic proximity Read ↗

Update on primary HIV-1 resistance in Argentina: emergence of mutations conferring high-level resistance to nonnucleoside reverse transcriptase inhibitors in drug-naive patients.Semantic proximity Read ↗

Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile.Semantic proximity Read ↗

[Comparison of three genotyping methods for the detection of HIV-1 resistance to antiretroviral drugs].Semantic proximity Read ↗

Genetic diversity among human immunodeficiency virus-1 non-B subtypes in viral load and drug resistance assays.Semantic proximity Read ↗

Subtype and genotypic resistance analysis of HIV-1 infected patients in Austria.Semantic proximity Read ↗

Genotypic resistance tests for the management of the HIV-infected patient with non-B viral isolates.Semantic proximity Read ↗

HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.Semantic proximity Read ↗

Molecular epidemiology of HIV type 1 in newly diagnosed patients in southern Spain.Semantic proximity Read ↗

Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence.Semantic proximity Read ↗

HIV type 1 genetic diversity surveillance among newly diagnosed individuals from 2003 to 2005 in Buenos Aires, Argentina.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.